Elevated plasma hemoglobin levels increase nitric oxide consumption in experimental and clinical acute pulmonary thromboembolism

Critical Care Medicine

Volumn 41, Issue 7, 2013, Pages

  Sertório, Jonas T ^a   Neto Neves, Evandro M ^b   Dias Junior, Carlos A ^c   Sousa Santos, Ozélia ^b   Kiss, Tamás ^d   Mühl, Diána ^d   Tanus Santos, Jose E ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

acute pulmonary thromboembolism; consumption; hemoglobin; hemolysis; nitric oxide; pulmonary embolism; pulmonary hypertension

Indexed keywords

ALTEPLASE; HEMOGLOBIN; NITRIC OXIDE; STREPTOKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; LAMB; LUNG ARTERY PRESSURE; LUNG EMBOLISM; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HEMOGLOBINS; MALE; NITRIC OXIDE; PULMONARY EMBOLISM; SHEEP;

EID: 84880570889     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31827c0b43     Document Type: Article

References (38)

1. Elliott CG: Pulmonary physiology during pulmonary embolism. Chest 1992; 101(4 Suppl):163S-171S
2. Smulders YM: Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: The pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000; 48:23-33
3. Smulders YM: Contribution of pulmonary vasoconstriction to haemodynamic instability after acute pulmonary embolism. Implications for treatment? Neth J Med 2001; 58:241-247
4. Dias-Junior CA, Neto-Neves EM, Montenegro MF, et al: Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. Nitric Oxide 2010; 23:284-288
5. Dias-Junior CA, Vieira TF, Moreno H Jr, et al: Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. Pulm Pharmacol Ther 2005; 18:181-186
6. Dias-Junior CA, Tanus-Santos JE: Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sci 2006; 79:469-474
7. Souza-Silva AR, Dias-Junior CA, Uzuelli JA, et al: Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolisminduced pulmonary hypertension. Eur J Pharmacol 2005; 524:126-131
8. Bonatti HJ, Harris T, Bauer T, et al: Transfemoral catheter thrombolysis and use of sildenafil in acute massive pulmonary embolism. J Cardiothorac Vasc Anesth 2010; 24:980-984
9. Bonatti HJ, Sawyer RG, Hagspiel KD. Use of sildenafil in a liver transplant recipient with acute pulmonary embolism. Eur Surg 2010; 42(1):65-67.
10. Ganière V, Feihl F, Tagan D: Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Intensive Care Med 2006; 32:452-454
11. Lewis GD, Bloch KD, Semigran MJ: Pulmonary thromboembolism superimposed on a congenital ventricular septal defect in a 50-yearold man inhaled nitric oxide and sildenafil to the rescue. Cardiol Rev 2004; 12:188-190
12. Watts JA, Gellar MA, Fulkerson MB, et al: Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism. Pulm Pharmacol Ther 2012; 25:48-54
13. Watts JA, Marchick MR, Gellar MA, et al: Up-regulation of arginase II contributes to pulmonary vascular endothelial cell dysfunction during experimental pulmonary embolism. Pulm Pharmacol Ther 2011; 24:407-413
14. Reiter CD, Wang X, Tanus-Santos JE, et al: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8:1383-1389
15. Sandrim VC, Montenegro MF, Palei AC, et al: Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia. Free Radic Biol Med 2010; 49:493-500
16. Vermeulen Windsant IC, de Wit NC, Sertorio JT, et al: Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Crit Care 2012; 16:R95
17. Donadee C, Raat NJ, Kanias T, et al: Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124:465-476
18. Gladwin MT, Kim-Shapiro DB: Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis. Curr Opin Hematol 2009; 16:515-523
19. Kim-Shapiro DB, Lee J, Gladwin MT: Storage lesion: Role of red blood cell breakdown. Transfusion 2011; 51:844-851
20. Dias-Junior CA, Gladwin MT, Tanus-Santos JE: Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism. Free Radic Biol Med 2006; 41:1764-1770
21. Mühl D, Ghosh S, Uzuelli JA, et al: Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thromb Res 2010; 125:549-553
22. Torbicki A, Perrier A, Konstantinides S, et al; ESC Committee for Practice Guidelines (CPG): Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29:2276-2315
23. Martin M, Fiebach BJ: Short-term ultrahigh streptokinase treatment of chronic arterial occlusions and acute deep vein thromboses. Semin Thromb Hemost 1991; 17:21-38
24. Wang X, Tanus-Santos JE, Reiter CD, et al: Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci USA 2004; 101:11477-11482
25. Barnes PJ, Liu SF: Regulation of pulmonary vascular tone. Pharmacol Rev 1995; 47:87-131
26. Dias-Junior CA, Sertorio JT, Tanus-Santos JE: Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism. Acta Physiol (Oxf) 2007; 191:189-196
27. Gladwin MT, Crawford JH, Patel RP: The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med 2004; 36:707-717
28. Kato GJ, Gladwin MT: Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA 2008; 300:2638-2646
29. Rother RP, Bell L, Hillmen P, et al: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 2005; 293:1653-1662
30. Schmid C, Zietlow S, Wagner TO, et al: Fulminant pulmonary embolism: symptoms, diagnostics, operative technique, and results. Ann Thorac Surg 1991; 52:1102-5; discussion 1105
31. Metz D, Nazeyrollas P, Mailier B, et al: Regression of right ventricular hypokinesis after thrombolysis in acute pulmonary embolism. Am J Cardiol 1996; 77:1252-1254
32. Hsu LL, Champion HC, Campbell-Lee SA, et al: Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007; 109:3088-3098
33. Kato GJ, McGowan V, Machado RF, et al: Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006; 107:2279-2285
34. Morris CR, Kato GJ, Poljakovic M, et al: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005; 294:81-90
35. Villagra J, Shiva S, Hunter LA, et al: Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007; 110:2166-2172
36. Neto-Neves EM, Dias-Junior CA, Uzuelli JA, et al: Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. Eur J Pharmacol 2011; 670:554-560
37. Dias-Junior CA, Montenegro MF, Florencio BC, et al: Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. Basic Clin Pharmacol Toxicol 2008; 103:374-379
38. Minneci PC, Deans KJ, Zhi H, et al: Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005; 115:3409-3417